-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – MV-140 in Urinary Tract Infections
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MV-140 in Urinary Tract Infections Drug Details: MV-140 (Uromune) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OPN-7486 in Leukocyte Disorders (White Blood Cell Disorders)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.OPN-7486 in Leukocyte Disorders (White Blood Cell Disorders) Drug Details:OPN-7486 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Sqz-Aacs (Oncology) in Anal Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Sqz-Aacs (Oncology) in Anal CancerDrug Details:Cell therapy is under development for the treatment of HPV16+ solid...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Arsenic Trioxide in Myeloproliferative Disorders
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Arsenic Trioxide in Myeloproliferative Disorders Drug Details:Arsenic trioxide is under development for the treatment of relapsed...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Afamitresgene Autoleucel in Gastric Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Afamitresgene Autoleucel in Gastric Cancer Drug Details:ADPA-2M4 is under development for the treatment of solid tumors...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – XT-150 in Neuropathic Pain (Neuralgia)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.XT-150 in Neuropathic Pain (Neuralgia) Drug Details:XT-150 is under development for the treatment of neuropathic pain,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Vofatamab in Relapsed Multiple Myeloma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Vofatamab in Relapsed Multiple Myeloma Drug Details: Vofatamab (B-701, RG-7444) is under development for the...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OPN-2853 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OPN-2853 in Solid Tumor Drug Details: PLX-2853 is under development for the treatment of myelofibrosis,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OPN-2853 in Follicular Lymphoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OPN-2853 in Follicular Lymphoma Drug Details: PLX-2853 is under development for the treatment of myelofibrosis,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – OPN-2853 in Myelofibrosis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. OPN-2853 in Myelofibrosis Drug Details: PLX-2853 is under development for the treatment of myelofibrosis, solid...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.